 |
Panobinostat |
|---|---|
| Trade Name | Faridak |
| Orphan Indication | Cutaneous T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2007-09-26 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corporation;One Health Plaza;East Hanover, New Jersey, 07936 |
Related Access Program